Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionIHT Wealth Management, LLC
Latest Disclosed Ownership13,562 shares
Latest Disclosed Value $ 4,771,626
IHT Wealth Management, LLC reports 2.44% increase in ownership of AMGN / Amgen Inc.

On May 15, 2026 - IHT Wealth Management, LLC filed a 13F-HR form disclosing ownership of 13,562 shares of Amgen Inc. (MX:AMGN) valued at $4,771,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 13,239 shares of Amgen Inc.. This represents a change in shares of 2.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Amgen COM 031162100 13,562 323 2.44 4,772 9.85 0.1104
2026-02-17 2025-12-31 13F Amgen COM 031162100 13,239 726 5.80 4,343 22.72 0.1055
2025-11-14 2025-09-30 13F Amgen COM 031162100 12,513 91 0.73 3,540 2.05 0.0895
2025-08-14 2025-06-30 13F Amgen COM 031162100 12,422 71 0.57 3,468 -9.85 0.0953
2025-05-15 2025-03-31 13F Amgen COM 031162100 12,351 -432 -3.38 3,848 15.49 0.1202
2025-02-14 2024-12-31 13F Amgen COM 031162100 12,783 18 0.14 3,332 -18.95 0.1075
2024-11-14 2024-09-30 13F Amgen COM 031162100 12,765 1,210 10.47 4,111 13.85 0.1166
2024-08-14 2024-06-30 13F AMGEN COM 031162100 11,555 132 1.16 3,610 11.18 0.1347
2024-05-15 2024-03-31 13F Amgen COM 031162100 11,423 -6 -0.05 3,248 -1.34 0.1302
2024-02-14 2023-12-31 13F AMGEN COM 031162100 11,429 -947 -7.65 3,292 -1.05 0.1468
2023-11-14 2023-09-30 13F AMGEN COM 031162100 12,376 1,055 9.32 3,326 32.35 0.1687
2023-08-15 2023-06-30 13F AMGEN COM 031162100 11,321 2,306 25.58 2,513 15.33 0.1309
2023-05-15 2023-03-31 13F AMGEN COM 031162100 9,015 352 4.06 2,179 -4.22 0.1244
2023-02-15 2022-12-31 13F AMGEN COM 031162100 8,663 -115 -1.31 2,275 14.96 0.1429
2022-11-22 2022-09-30 13F AMGEN COM 031162100 8,778 2,790 46.59 1,979 35.83 0.1504
2022-08-15 2022-06-30 13F AMGEN COM 031162100 5,988 212 3.67 1,457 4.29 0.1284
2022-05-16 2022-03-31 13F AMGEN COM 031162100 5,776 31 0.54 1,397 8.04 0.1059
2022-02-14 2021-12-31 13F AMGEN COM 031162100 5,745 -216 -3.62 1,293 1.97 0.0953
2021-11-15 2021-09-30 13F AMGEN COM 031162100 5,961 -3,536 -37.23 1,268 -45.23 0.1032
2021-08-16 2021-06-30 13F AMGEN COM 031162100 9,497 2,427 34.33 2,315 31.61 0.1468
2021-05-18 2021-03-31 13F AMGEN COM 031162100 7,070 89 1.27 1,759 9.60 0.1265
2021-02-17 2020-12-31 13F AMGEN COM 031162100 6,981 577 9.01 1,605 -1.41 0.1334
2020-11-19 2020-09-30 13F AMGEN COM 031162100 6,404 591 10.17 1,628 18.75 0.1634
2020-08-14 2020-06-30 13F AMGEN COM 031162100 5,813 -1,756 -23.20 1,371 -10.63 0.1878
2020-05-13 2020-03-31 13F AMGEN COM 031162100 7,569 209 2.84 1,534 -13.53 0.2209
2020-02-18 2019-12-31 13F AMGEN COM 031162100 7,360 402 5.78 1,774 31.70 0.2101
2019-11-15 2019-09-30 13F AMGEN COM 031162100 6,958 872 14.33 1,347 20.05 0.1832
2019-08-12 2019-06-30 13F AMGEN COM 031162100 6,086 -278 -4.37 1,122 -7.20 0.1629
2019-05-16 2019-03-31 13F AMGEN COM 031162100 6,364 -1,130 -15.08 1,209 -17.14 0.2014
2019-02-14 2018-12-31 13F AMGEN COM 031162100 7,494 303 4.21 1,459 -2.15 0.2808
2018-11-14 2018-09-30 13F AMGEN COM 031162100 7,191 222 3.19 1,491 15.94 0.3225
2018-08-13 2018-06-30 13F AMGEN COM 031162100 6,969 1,035 17.44 1,286 30.56 0.3286
2018-05-14 2018-03-31 13F AMGEN COM 031162100 5,934 -818 -12.11 985 -19.20 0.2645
2018-02-14 2017-12-31 13F AMGEN COM 031162100 6,752 2,227 49.22 1,219 45.29 0.3227
2017-11-14 2017-09-30 13F AMGEN COM 031162100 4,525 1,934 74.64 839 4,315.79 0.3572
2017-08-14 2017-06-30 13F/A-1 AMGEN COM 031162100 2,591 648 33.35 19 -93.97 0.0092
2017-08-14 2017-06-30 13F AMGEN COM 031162100 2,591 648 113
2017-05-15 2017-03-31 13F AMGEN COM 031162100 1,943 -360 -15.63 315 -9.22 0.2100
2017-02-14 2016-12-31 13F AMGEN COM 031162100 2,303 2,303 347 0.2624
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.